CompletedNCT00094393

Clinical Studies of Progeria

Studying Hutchinson-Gilford progeria syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Human Genome Research Institute (NHGRI)
Principal Investigator: William A Gahl, M.D.
National Human Genome Research Institute (NHGRI)
Enrollment: 15 enrolled
Eligibility: 70 years · All sexes
Timeline: 2004 – 2018

Study locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00094393 on ClinicalTrials.gov

Other trials for Hutchinson-Gilford progeria syndrome

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT06775041
Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)
PRG Science & Technology Co., Ltd.

See all trials for Hutchinson-Gilford progeria syndrome →

← Back to all trials